178 related articles for article (PubMed ID: 25071913)
1. β-Catenin activated hepatocellular adenoma: a report of three cases in Korea.
Kim GJ; Seok JY; Rhee H; Choi JY; Choi JS; Kim KS; Thung S; Park YN
Gut Liver; 2014 Jul; 8(4):452-8. PubMed ID: 25071913
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
Shafizadeh N; Genrich G; Ferrell L; Kakar S
Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry.
Bioulac-Sage P; Rebouissou S; Thomas C; Blanc JF; Saric J; Sa Cunha A; Rullier A; Cubel G; Couchy G; Imbeaud S; Balabaud C; Zucman-Rossi J
Hepatology; 2007 Sep; 46(3):740-8. PubMed ID: 17663417
[TBL] [Abstract][Full Text] [Related]
4.
Longerich T; Endris V; Neumann O; Rempel E; Kirchner M; Abadi Z; Uhrig S; Kriegsmann M; Weiss KH; Breuhahn K; Mehrabi A; Weber TF; Wilkens L; Straub BK; Rosenwald A; Schulze F; Brors B; Froehling S; Pellegrino R; Budczies J; Schirmacher P; Stenzinger A
Gut; 2019 Jul; 68(7):1287-1296. PubMed ID: 30901310
[TBL] [Abstract][Full Text] [Related]
5. A Limited Immunohistochemical Panel Can Subtype Hepatocellular Adenomas for Routine Practice.
Larson BK; Guindi M
Am J Clin Pathol; 2017 Jun; 147(6):557-570. PubMed ID: 28472207
[TBL] [Abstract][Full Text] [Related]
6. Subtype classification of hepatocellular adenoma.
Bioulac-Sage P; Balabaud C; Zucman-Rossi J
Dig Surg; 2010; 27(1):39-45. PubMed ID: 20357450
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma arising in a pigmented telangiectatic adenoma with nuclear β-catenin and glutamine synthetase positivity: case report and review of the literature.
Hechtman JF; Raoufi M; Fiel MI; Taouli B; Facciuto M; Schiano TD; Blouin AG; Thung SN
Am J Surg Pathol; 2011 Jun; 35(6):927-32. PubMed ID: 21572265
[TBL] [Abstract][Full Text] [Related]
8. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
Nault JC; Couchy G; Balabaud C; Morcrette G; Caruso S; Blanc JF; Bacq Y; Calderaro J; Paradis V; Ramos J; Scoazec JY; Gnemmi V; Sturm N; Guettier C; Fabre M; Savier E; Chiche L; Labrune P; Selves J; Wendum D; Pilati C; Laurent A; De Muret A; Le Bail B; Rebouissou S; Imbeaud S; ; Bioulac-Sage P; Letouzé E; Zucman-Rossi J
Gastroenterology; 2017 Mar; 152(4):880-894.e6. PubMed ID: 27939373
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience.
Bioulac-Sage P; Laumonier H; Couchy G; Le Bail B; Sa Cunha A; Rullier A; Laurent C; Blanc JF; Cubel G; Trillaud H; Zucman-Rossi J; Balabaud C; Saric J
Hepatology; 2009 Aug; 50(2):481-9. PubMed ID: 19585623
[TBL] [Abstract][Full Text] [Related]
10. Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice.
van Aalten SM; Verheij J; Terkivatan T; Dwarkasing RS; de Man RA; Ijzermans JN
J Hepatol; 2011 Jul; 55(1):120-5. PubMed ID: 21145863
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous Occurrence of Various Types of Hepatocellular Adenoma in the Livers of Metabolic Syndrome-Associated Steatohepatitis Model TSOD Mice.
Shao W; Jargalsaikhan O; Ichimura-Shimizu M; Cai Q; Ogawa H; Miyakami Y; Atsumi K; Tomita M; Sutoh M; Toyohara S; Hokao R; Kudo Y; Oya T; Tsuneyama K
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233225
[TBL] [Abstract][Full Text] [Related]
12. Correlation of exon 3 β-catenin mutations with glutamine synthetase staining patterns in hepatocellular adenoma and hepatocellular carcinoma.
Hale G; Liu X; Hu J; Xu Z; Che L; Solomon D; Tsokos C; Shafizadeh N; Chen X; Gill R; Kakar S
Mod Pathol; 2016 Nov; 29(11):1370-1380. PubMed ID: 27469330
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic characterization of hepatocellular adenomas in men: a multicenter experience.
González IA; Torbenson M; Sharifai N; Byrnes K; Chatterjee D; Kakar S; Yeh MM; Wu TT; Zhang X; Jain D
Hum Pathol; 2023 Aug; 138():24-33. PubMed ID: 37245629
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular adenomas in the Turkish population: reclassification according to updated World Health Organization criteria.
Deniz K; Umetsu SE; Ferrell L; Yılmaz F; Güllüoğlu M; Sağol Ö; Doğusoy GB; Kırımlıoğlu H; Turhan N; Doran F; Kepil N; Çelikel ÇA; Nart D; Özgüven BY; Ceyran B; Karadağ N; Kır G; Erden E; Yılmaz G; Akyol G
Histopathology; 2021 Jul; 79(1):23-33. PubMed ID: 33406290
[TBL] [Abstract][Full Text] [Related]
15. Malignant transformation of a β-catenin inflammatory adenoma due to an S45 β-catenin-activating mutation present 12 years before.
Sempoux C; Bisig B; Couchy G; Balabaud C; Zucman-Rossi J; Bioulac-Sage P
Hum Pathol; 2017 Apr; 62():122-125. PubMed ID: 27984126
[TBL] [Abstract][Full Text] [Related]
16. Atypical hepatocellular adenoma-like neoplasms with β-catenin activation show cytogenetic alterations similar to well-differentiated hepatocellular carcinomas.
Evason KJ; Grenert JP; Ferrell LD; Kakar S
Hum Pathol; 2013 May; 44(5):750-8. PubMed ID: 23084586
[TBL] [Abstract][Full Text] [Related]
17. Malignant transformation of hepatic adenomas.
Micchelli ST; Vivekanandan P; Boitnott JK; Pawlik TM; Choti MA; Torbenson M
Mod Pathol; 2008 Apr; 21(4):491-7. PubMed ID: 18246041
[TBL] [Abstract][Full Text] [Related]
18. Diffuse glutamine synthetase overexpression restricted to areas of peliosis in a β-catenin-activated hepatocellular adenoma: a potential pitfall in glutamine synthetase interpretation.
Berry RS; Gullapalli RR; Wu J; Morris K; Hanson JA
Virchows Arch; 2014 Aug; 465(2):241-5. PubMed ID: 24997695
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular Carcinoma Arising in a Huge Hepatocellular Adenoma with Bone Marrow Metaplasia.
Kang HJ; Jeong HJ; Kim SW; Yu E; Lee YJ; Kim SY; Kim J
J Pathol Transl Med; 2018 Jul; 52(4):226-231. PubMed ID: 29281780
[TBL] [Abstract][Full Text] [Related]
20. A case of β-catenin-positive hepatocellular adenoma with MR imaging sign of diffuse intratumoral fat deposition.
Ishii M; Kazaoka J; Fukushima J; Gunji M; Aoyama T; Fukusato T; Sano K; Kondo F; Takeshita T; Furui S; Akahane M
Abdom Imaging; 2015 Aug; 40(6):1487-91. PubMed ID: 25875860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
